Volume 138, Issue 2, Pages e1 (February 2010)

Slides:

Advertisements

Similar presentations

Increased Levels of Arginase in Patients With Acute Hepatitis B Suppress Antiviral T Cells Elena Sandalova, Diletta Laccabue, Carolina Boni, Tsunamasa.

Advertisements

Volume 152, Issue 5, Pages e1 (April 2017)

Efficacy and Safety of Oral Chelators in Treatment of Patients With Wilson Disease Karl Heinz Weiss, Florentine Thurik, Daniel Nils Gotthardt, Mark Schäfer,

Volume 146, Issue 2, Pages e6 (February 2014)

The Value of a 24/7 Online Nationwide Multidisciplinary Expert Panel for Acute Necrotizing Pancreatitis Janneke van Grinsven, Sandra van Brunschot Gastroenterology

Gastrointestinal Stromal Tumors: Disease and Treatment Update

Volume 140, Issue 2, Pages e1 (February 2011)

Christoph Lübbert, Babett Holler Gastroenterology

The Value of a 24/7 Online Nationwide Multidisciplinary Expert Panel for Acute Necrotizing Pancreatitis Janneke van Grinsven, Sandra van Brunschot Gastroenterology

Cost-Effectiveness of Access Expansion to Treatment of Hepatitis C Virus Infection Through Primary Care Providers Thilo Rattay, Ian P. Dumont, Hauke.

Covering the Cover Gastroenterology

Spontaneous Self-Expulsion of a Large Stone From the Abdomen

Effectiveness of Hepatitis B Treatment in Clinical Practice

Impact of IL28B Genotype on the Early and Sustained Virologic Response in Treatment- Naïve Patients With Chronic Hepatitis C Albert Friedrich Stättermayer,

Improved Virologic Response in Chronic Hepatitis C Genotype 4 Treated With Nitazoxanide, Peginterferon, and Ribavirin Jean–François Rossignol, Asem Elfert,

Volume 149, Issue 2, Pages e3 (August 2015)

Ira J. Fox, Stephen C. Strom Gastroenterology

Boceprevir With Peginterferon Alfa-2a–Ribavirin Is Effective for Previously Treated Chronic Hepatitis C Genotype 1 Infection Steven L. Flamm, Eric Lawitz,

Electronic Clinical Challenges and Images in GI

Proton-Pump Inhibitor Therapy Induces Acid-Related Symptoms in Healthy Volunteers After Withdrawal of Therapy Christina Reimer, Bo Søndergaard, Linda.

Volume 140, Issue 2, Pages e1 (February 2011)

Unusual Case of an Upset Stomach

Volume 153, Issue 3, Pages e16-e17 (September 2017)

Volume 150, Issue 4, Pages (April 2016)

Volume 154, Issue 4, Pages (March 2018)

An Unusual Incidental Finding in a Patient With Colon Perforation

Efficacy and Safety of Oral Chelators in Treatment of Patients With Wilson Disease Karl Heinz Weiss, Florentine Thurik, Daniel Nils Gotthardt, Mark Schäfer,

Volume 155, Issue 5, Pages e2 (November 2018)

Diagnostic Value of Quantitative Hepatic Copper Determination in Patients With Wilson’s Disease Peter Ferenci, Petra Steindl-Munda, Wolfgang Vogel, Wolfgang.

Late-Onset Wilson’s Disease

Multiple Masses in the Colon of a Patient With Ulcerative Colitis

Sonia Radunz, Hideo A. Baba, Georgios C. Sotiropoulos Gastroenterology

Volume 146, Issue 2, Pages e6 (February 2014)

A Rare Cause of Postprandial Abdominal Pain and Nausea

Volume 156, Issue 3, Pages (February 2019)

A. Sidney Barritt, Michael W. Fried Gastroenterology

A High-Fiber Diet Does Not Protect Against Asymptomatic Diverticulosis

Volume 135, Issue 5, Pages (November 2008)

Gastrointestinal Stromal Tumors: Disease and Treatment Update

AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review Jean-Frederic Colombel,

Volume 146, Issue 3, Pages (March 2014)

Volume 141, Issue 1, Pages e1 (July 2011)

Volume 142, Issue 6, Pages (May 2012)

Laura Rotundo, Sushil Ahlawat Gastroenterology

Rafael Esteban, Maria Buti Gastroenterology

Volume 149, Issue 1, Pages e6 (July 2015)

Volume 145, Issue 4, Pages e3 (October 2013)

Ashwin N. Ananthakrishnan, David Lieberman Gastroenterology

Volume 148, Issue 3, Pages (March 2015)

Jeremy P. Dwyer, Patrick Hosking, John Lubel Gastroenterology

Statin Therapy Improves Sustained Virologic Response Among Diabetic Patients With Chronic Hepatitis C Gowtham A. Rao, Prashant K. Pandya Gastroenterology

Covering the Cover Gastroenterology

The Dawning of a New Editorial Board for Gastroenterology

Secondary Prophylaxis of Hepatic Encephalopathy: An Open-Label Randomized Controlled Trial of Lactulose Versus Placebo Barjesh Chander Sharma, Praveen.

Probiotics Prevent Hepatic Encephalopathy in Patients With Cirrhosis: A Randomized Controlled Trial Manish Kumar Lunia, Barjesh Chander Sharma, Praveen.

Volume 147, Issue 2, Pages e1 (August 2014)

Electronic Clinical Challenges and Images in GI

Meta-analysis Shows Extended Therapy Improves Response of Patients With Chronic Hepatitis C Virus Genotype 1 Infection Harald Farnik, Christian M. Lange,

Electronic Clinical Challenges and Images in GI

Volume 139, Issue 6, Pages e1 (December 2010)

Volume 139, Issue 5, Pages (November 2010)

Recurrent Acute Pancreatitis in a Young Woman With a History of Asymptomatic Lipase Elevations for Several Years Christian P. Strassburg, Michael P.

Volume 135, Issue 2, Pages (August 2008)

Electronic Clinical Challenges and Images in GI

Electronic Clinical Challenges and Images in GI

Controversies in Liver Transplantation for Hepatitis C

A Female Patient With Persistent Epigastric Pain for 1 Week

Induction Pegylated Interferon Alfa-2b in Combination With Ribavirin in Patients With Genotypes 1 and 4 Chronic Hepatitis C: A Prospective, Randomized,

Subcapsular Hepatic Fluid Collection Caused by Cardiac Dysfunction

Abnormal Gastrointestinal Imaging in a Patient With Dyspepsia

Presentation transcript:

Volume 138, Issue 2, Pages 503-512.e1 (February 2010) Peginterferon Alfa-2a/Ribavirin for 48 or 72 Weeks in Hepatitis C Genotypes 1 and 4 Patients With Slow Virologic Response Peter Ferenci, Hermann Laferl, Thomas–Matthias Scherzer, Andreas Maieron, Harald Hofer, Rudolf Stauber, Michael Gschwantler, Harald Brunner, Christoph Wenisch, Martin Bischof, Michael Strasser, Christian Datz, Wolfgang Vogel, Karin Löschenberger, Petra Steindl–Munda Gastroenterology Volume 138, Issue 2, Pages 503-512.e1 (February 2010) DOI: 10.1053/j.gastro.2009.10.058 Copyright © 2010 AGA Institute Terms and Conditions

Figure 1 Relapse rates in patients randomized to 48 or 72 weeks of treatment. Gastroenterology 2010 138, 503-512.e1DOI: (10.1053/j.gastro.2009.10.058) Copyright © 2010 AGA Institute Terms and Conditions

Supplementary Figure 1 Flow of patients through the trial. Group B includes 1 patient who initiated treatment after the deadline for initiating treatment. Gastroenterology 2010 138, 503-512.e1DOI: (10.1053/j.gastro.2009.10.058) Copyright © 2010 AGA Institute Terms and Conditions